Predictors of 1- and 12-month mortality in bifurcation coronary intervention: a contemporary perspective

Majd B Protty1,2, Tom Valenzuela1, Ahmed Sharaf1

  • 1Department of Cardiology, Morriston Cardiac Centre, Swansea, SA6 6NL, UK.

Future Cardiology
|July 14, 2023
PubMed

Insights

This study identified key factors like age, diabetes, smoking, and renal failure influencing mortality after bifurcation percutaneous coronary intervention (PCI). The choice of stent strategy did not significantly affect outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Bifurcation percutaneous coronary intervention (PCI) is a common procedure.
  • There is a lack of definitive evidence for optimal strategies in complex bifurcation PCI.
  • Understanding real-world outcomes is crucial for improving patient care.

Purpose of the Study:

  • To identify factors associated with 1- and 12-month mortality after bifurcation PCI.
  • To analyze outcomes in a large cohort from a tertiary center in Wales, UK.

Main Methods:

  • Retrospective analysis of 732 bifurcation PCI cases performed between 2017 and 2021.
  • Data collected on patient demographics, clinical presentation, procedural details, and outcomes.

Main Results:

  • The study included 732 patients (mean age 69, 25% female), with 67% presenting with acute coronary syndrome (ACS).
  • 30-day and 12-month mortality rates were 1.9% and 8.2%, respectively.
  • Factors associated with mortality included age, diabetes, smoking, and renal failure. The choice between provisional and two-stent strategies did not impact mortality or target lesion revascularization (TLR).

Conclusions:

  • Real-world outcomes of bifurcation PCI highlight the importance of patient selection and procedural planning.
  • Awareness of associated mortality factors can guide technique selection and informed patient consent.
  • Further research may refine strategies for complex bifurcation interventions.